Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89%
PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR.
Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut.
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and the government of Sierra Leone have begun administering the Company’s Ebola vaccine regimen as part of a WHO early access clinical program aimed at preventing further spread of Ebola in West Africa.
“The African American community, in general, has the highest prevalence of cardiovascular diseases,” says Rachel Bond, M.D., System Director of the Women’s Heart Health Program for Dignity Health in Arizona
Since the YCBDA family planning counseling initiative started, the district has registered a reduction in teenage pregnancy from 28% to 19% (DHIS 2, April -June 2021).